Nanoparticle Albumin-Bound Rapamycin

The macrolide antibiotic rapamycin bound to nanoparticle albumin with immunosuppressant (see sirolimus) and potential antiangiogenic and antineoplastic activities. Rapamycin binds to the immunophilin FK Binding Protein-12 (FKBP-12) to generate a complex that binds to and inhibits the activation of the mammalian Target Of Rapamycin (mTOR), a key regulatory kinase. In turn, inhibition of mTOR may result in the inhibition of the phosphatidylinositol 3 (PI-3) kinase/Akt pathway and vascular endothelial cell growth factor (VEGF) secretion, which may result in decreased tumor cell proliferation and tumor angiogenesis. The binding of water-insoluble rapamycin to nanoparticle albumin permits the albumin-mediated endocytosis of rapamycin by tumor cells and endothelial cells. (NCI Thesaurus)

YOU MAY ALSO LIKE

Nanoparticle Albumin-Bound Docetaxel

A nanoparticle albumin-bound formulation of the taxane docetaxel with antineoplastic activity. Docetaxel is a semi-synthetic, second-generation taxane derived from a compound found…

Nanoparticle

A nanoscale spherical or capsule-shaped structure. Most, though not all, nanoparticles are hollow, which provides a central reservoir that can be filled…

Nanomole per Second

Nanomoles per second.

Nanomole per Minute per Milliliter

A unit of concentration (molarity unit) equal to one billionth of a mole (10E-9 mole) of solute per minute per milliliter. …

Nanomole per Minute

Nanomoles per minute.

Nanomole per Milliliter per Hour

Nanomoles per milliliter per hour.